PMN310 has been granted Fast Track Designation by the U.S. FDA for the treatment of Alzheimer’s disease.
Upcoming Events
There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.
PMN310 has been granted Fast Track Designation by the U.S. FDA for the treatment of Alzheimer’s disease.
There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.